An alteration of ganglioside composition in cisplatin-resistant lung cancer cell line

Anticancer Res. 1998 Jul-Aug;18(4C):2957-60.

Abstract

Previously we established cell lines resistant to Adriamycin and cisplatin to elucidate the mechanisms involved in acquired drug-resistance. In this study, we investigated ganglioside composition in drug-resistant cell lines. The Adriamycin-resistant cell line, SBC-3/ADM100, exhibited a ganglioside composition ratio similar to that of the parent SBC-3 cells. Densitometric analysis by resorcinol showed a 1.61-fold increase of ganglioside GM2 in SBC-3/ADM100 cells, when compared to the parent SBC-3 cells. The cisplatin-resistant cell line, SBC-3/CDDP, showed a simplified ganglioside pattern, expressing only gangliosides GM3 and GM2. SBC-3/CDDP cells showed a marked increase in ganglioside GM3. These findings suggest that the alteration of ganglioside composition may be actively involved in the acquisition of drug-resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / metabolism*
  • Chromatography, High Pressure Liquid
  • Chromatography, Thin Layer
  • Cisplatin / pharmacology*
  • Drug Resistance, Neoplasm
  • Flow Cytometry
  • G(M2) Ganglioside / metabolism*
  • G(M3) Ganglioside / metabolism*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • G(M3) Ganglioside
  • G(M2) Ganglioside
  • Cisplatin